|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.71 USD | -4.24% |
|
-4.58% | -53.68% |
Augmedix, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 44.86 million compared to USD 30.93 million a year ago. Net loss was USD 19.17 million compared to USD 24.45 million a year ago.
Basic loss per share from continuing operations was USD 0.44 compared to USD 0.65 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -53.68% | 138M | |
| +9.24% | 67.56B | |
| +10.58% | 18.33B | |
| +7.01% | 13.47B | |
| +19.90% | 13.36B | |
| +16.44% | 9.99B | |
| -35.27% | 5.82B | |
| -11.44% | 5.6B | |
| -4.27% | 4.94B | |
| -6.00% | 4.89B |
AUGMEDIX, INC. 
